| 组别 | 例数 | IL-21+IFN-γ−Tfh/Tfh (%) | t | P | IL-21+IFN-γ+Tfh/Tfh (%) | t | P |
| Rai分期 |
|
| −1.37 | 0.181 |
| −1.37 | 0.560 |
| 0期 | 4 | 3.46 ± 2.73 |
|
| 24.26 ± 8.57 |
|
|
| I~IV期 | 26 | 5.37 ± 2.56 |
|
| 22.14 ± 6.42 |
|
|
| Binet分期 |
|
| −0.81 | 0.421 |
| −0.52 | 0.609 |
| A期 | 7 | 4.73 ± 2.70 |
|
| 21.28 ± 5.97 |
|
|
| B~C期 | 23 | 5.65 ± 2.57 |
|
| 22.77 ± 6.87 |
|
|
| IPI指数 |
|
| −0.88 | 0.382 |
| −2.19 | 0.036* |
| 低、中危 | 21 | 5.16 ± 2.71 |
|
| 19.58 ± 4.55 |
|
|
| 高、极高危 | 9 | 6.08 ± 2.62 |
|
| 23.66 ± 4.92 |
|
|
| IGVH突变 |
|
| −0.78 | 0.438 |
| −1.98 | 0.030* |
| 阳性 | 10 | 4.90 ± 2.44 |
|
| 19.19 ± 4.52 |
|
|
| 阴性 | 20 | 5.69 ± 2.66 |
|
| 24.04 ± 6.97 |
|